Literature DB >> 17306980

A new modification of anti-tubercular active molecules.

Ales Imramovský1, Slovenko Polanc, Jarmila Vinsová, Marijan Kocevar, Josef Jampílek, Zuzana Recková, Jarmila Kaustová.   

Abstract

The connection of two active molecules across an easily released bridge as a new type of potentially active molecule has been studied. The synthesis is based on derivatives that originate from isonicotinoyl hydrazide, pyrazinamide, p-aminosalicylic acid (PAS), ethambutol, and ciprofloxacin. The lipophilicity, hydrolysis (stability of the compounds), and antituberculotic activity as well as the structure-lipophilicity and structure-activity relationships are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306980     DOI: 10.1016/j.bmc.2007.01.051

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Synthesis, anticonvulsant and neurotoxicity evaluation of some new pyrimidine-5-carbonitrile derivatives.

Authors:  Mohammad Shaquiquzzaman; Suroor Ahmad Khan; Mohammad Amir; Mohammad Mumtaz Alam
Journal:  Saudi Pharm J       Date:  2011-09-24       Impact factor: 4.330

Review 2.  Biological activities of hydrazone derivatives.

Authors:  Sevim Rollas; S Güniz Küçükgüzel
Journal:  Molecules       Date:  2007-08-17       Impact factor: 4.411

3.  N,N-Bis(2,2-dimethyl-propano-yl)benzene-1,3-dicarbohydrazide.

Authors:  Hoong-Kun Fun; Suchada Chantrapromma; Subrata Jana; Anita Hazra; Shyamaprosad Goswami
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2007-12-06

4.  A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase.

Authors:  Shilah A Bonnett; Juliane Ollinger; Susantha Chandrasekera; Stephanie Florio; Theresa O'Malley; Megan Files; Jo-Ann Jee; James Ahn; Allen Casey; Yulia Ovechkina; David Roberts; Aaron Korkegian; Tanya Parish
Journal:  ACS Infect Dis       Date:  2016-09-19       Impact factor: 5.084

5.  Synthesis of New Fluoro-Benzimidazole Derivatives as an Approach towards the Discovery of Novel Intestinal Antiseptic Drug Candidates.

Authors:  Ulviye Acar Cevik; Begum Nurpelin Saglik; Yusuf Ozkay; Zerrin Canturk; Juan Bueno; Fatih Demirci; Ali Savas Koparal
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

6.  Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents.

Authors:  Singireddi Srinivasarao; Adinarayana Nandikolla; Amaroju Suresh; Kevin Van Calster; Linda De Voogt; Davie Cappoen; Balaram Ghosh; Himanshu Aggarwal; Sankaranarayanan Murugesan; Kondapalli Venkata Gowri Chandra Sekhar
Journal:  RSC Adv       Date:  2020-03-25       Impact factor: 3.361

7.  2-(1,3-Dioxoisoindolin-2-yl)acetic acid-N'-[(E)-2-meth-oxy-benzyl-idene]pyridine-4-carbohydrazide (1/1).

Authors:  Shaaban K Mohamed; Muhammad Akhyar Farrukh; Mehmet Akkurt; Mustafa R Albayati; Antar A Abdelhamid
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-14

8.  2-(1,3-Dioxoisoindolin-2-yl)acetic acid-N'-[(E)-4-meth-oxy-benzyl-idene]pyridine-4-carbohydrazide (2/1).

Authors:  Sladjana B Novaković; Goran A Bogdanović; Shaaban K Mohamed; Mustafa R Albayati; Ayad S Hameed
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-08

Review 9.  A review exploring biological activities of hydrazones.

Authors:  Garima Verma; Akranth Marella; Mohammad Shaquiquzzaman; Mymoona Akhtar; Mohammad Rahmat Ali; Mohammad Mumtaz Alam
Journal:  J Pharm Bioallied Sci       Date:  2014-04

10.  A class of hydrazones are active against non-replicating Mycobacterium tuberculosis.

Authors:  Shilah A Bonnett; Devon Dennison; Megan Files; Anumita Bajpai; Tanya Parish
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.